Get started
Author

Dijana Šagi

Observed names: D SAGI, D Sagi, D. Sagi, Dijana Sagi, Šagi, Dijana
OpenAlex ID: A5032124189
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
2004 · James J. Palacino, Dijana Sagi, et al. · Journal of Biological Chemistry · 995
A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If)
2001 · Christian Kranz, Jonas Denecke, et al. · Journal of Clinical Investigation · 131
PDF
Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti‐melanoma mouse IgG3 monoclonal antibody R24
2003 · Johannes Müthing, Sven E. Kemminer, et al. · Biotechnology and Bioengineering · 105
Sequencing of tri- and tetraantennary N-glycans containing sialic acid by negative mode ESI QTOF tandem MS
2002 · Dijana Sagi, Jasna Peter-Katalinic, et al. · Journal of the American Society for Mass Spectrometry · 82
Glycoproteomics of N ‐glycosylation by in‐gel deglycosylation and matrix‐assisted laser desorption/ionisation‐time of flight mass spectrometry mapping: Application to congenital disorders of glycosylation
2005 · Dijana Šagi, Petra Kienz, et al. · PROTEOMICS · 61
Comparative Proteomics in Neurodegenerative and Non-neurodegenerative Diseases Suggest Nodal Point Proteins in Regulatory Networking
2006 · Claus Zabel, Dijana Sagi, et al. · Journal of Proteome Research · 60
High MS‐compatibility of silver nitrate‐stained protein spots from 2‐DE gels using ZipPlates and AnchorChips for successful protein identification
2007 · Grit Nebrich, Marion Herrmann, et al. · Electrophoresis · 32
Estimation of the mtDNA mutation rate in aging mice by proteome analysis and mathematical modeling
2005 · L MAO, C ZABEL, et al. · Experimental Gerontology · 27
Oligomerization and substrate binding studies of the adenylate kinase from Sulfolobus acidocaldarius by matrix-assisted laser desorption/ionization mass spectrometry
2000 · Kerstin Strupat, Dijana Šagi, et al. · The Analyst · 24
Production and Molecular Characterization of Clinical Phase I Anti-Melanoma Mouse IgG3 Monoclonal Antibody R24
2001 · S.E. Kemminer, H.S. Conradt, et al. · Biotechnology Progress · 12
MALDI‐MS of Glycans
2007 · Dijana Šagi, Jasna Peter‐Katalinić · 4
MALDI‐MS of Glycans and Glycoconjugates
2013 · Hélène Perreault, Erika Lattová, et al. · 3
Proteomics in neurodegenerative diseases
2003 · D. Sagi, C. Zabel · Journal of Neurochemistry · 3
Hyperoxia causes brain proteome changes in infant mice
2004 · AM Kaindl, D Sagi, et al. · Neuropediatrics
Works count: 15
Citation count: 1,539
H-index: 10
I10-index: 10
Year
Topic
Type